Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Bijblijven 6/2018

15-06-2018

Hartfalen en COPD

Auteur: Prof. dr. Frans H. Rutten

Gepubliceerd in: Bijblijven | Uitgave 6/2018

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Er is veel overlap tussen hartfalen en COPD wat betreft diagnostiek, etiologie, prognose en behandeling.
Bij iedereen met COPD dient men ook te denken aan hartfalen. Niet-herkend hartfalen komt bij deze groep patiënten veel voor. Er is ook veel overlap in klachten. Kortademigheid is een kernsymptoom voor beide ziekten. Piepende ademhaling en hoesten komen ook bij hartfalen voor, terwijl verminderde inspanningstolerantie en vermoeidheid ook veelgehoorde symptomen zijn bij patiënten met COPD.
Gemeenschappelijke oorzaken voor COPD en hartfalen zijn roken en systemische inflammatie. COPD en hartfalen zijn chronisch progressieve ziekten die elkaar in negatieve zin versterken. Cardioselectieve bètablokkers mogen wel worden voorgeschreven aan patiënten met COPD.
Literatuur
1.
go back to reference Mulrow CD, Lucey CR, Farnett LE. Discriminating causes of dyspnea through clinical examination. J Gen Intern Med. 1993;8:383–92. CrossRefPubMed Mulrow CD, Lucey CR, Farnett LE. Discriminating causes of dyspnea through clinical examination. J Gen Intern Med. 1993;8:383–92. CrossRefPubMed
2.
go back to reference Mourik Y van, Rutten FH, Moons KG, Bertens LC, Hoes AW, Reitsma JB. Prevalence and underlying causes of dyspnoea in older people: a systematic review. Age Ageing. 2014;43:319–26. CrossRefPubMed Mourik Y van, Rutten FH, Moons KG, Bertens LC, Hoes AW, Reitsma JB. Prevalence and underlying causes of dyspnoea in older people: a systematic review. Age Ageing. 2014;43:319–26. CrossRefPubMed
3.
go back to reference Riet EE van, Hoes AW, Limburg A, Landman MA, Hoeven H van der, Rutten FH. Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion. Eur J Heart Fail. 2014;16:772–7. CrossRefPubMed Riet EE van, Hoes AW, Limburg A, Landman MA, Hoeven H van der, Rutten FH. Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion. Eur J Heart Fail. 2014;16:772–7. CrossRefPubMed
4.
go back to reference Valk MJ, Broekhuizen BD, Mosterd A, Zuithoff NP, Hoes AW, Rutten FH. COPD in patients with stable heart failure in the primary care setting. Int J Chron Obstruct Pulmon Dis. 2015;10:1219–24. CrossRefPubMedPubMedCentral Valk MJ, Broekhuizen BD, Mosterd A, Zuithoff NP, Hoes AW, Rutten FH. COPD in patients with stable heart failure in the primary care setting. Int J Chron Obstruct Pulmon Dis. 2015;10:1219–24. CrossRefPubMedPubMedCentral
5.
go back to reference Brenner S, Güder G, Berliner D, Deubner N, Fröhlich K, Ertl G, Jany B, Angermann CE, Störk S. Airway obstruction in systolic heart failure – COPD or congestion? Int J Cardiol. 2013;168(3):1910–6. CrossRefPubMed Brenner S, Güder G, Berliner D, Deubner N, Fröhlich K, Ertl G, Jany B, Angermann CE, Störk S. Airway obstruction in systolic heart failure – COPD or congestion? Int J Cardiol. 2013;168(3):1910–6. CrossRefPubMed
6.
go back to reference Rutten FH, Cramer M‑JM, Grobbee DE, Sachs APE, Kirkels JH, Lammers J‑WJ, Hoes AW. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J. 2005;26:1887–94. CrossRefPubMed Rutten FH, Cramer M‑JM, Grobbee DE, Sachs APE, Kirkels JH, Lammers J‑WJ, Hoes AW. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J. 2005;26:1887–94. CrossRefPubMed
7.
go back to reference Güder G, Brenner S, Störk S, Hoes A, Rutten FH. Chronic obstructive pulmonary disease in heart failure: accurate diagnosis and treatment. Eur J Heart Fail. 2014;16(12):1273–82. CrossRefPubMed Güder G, Brenner S, Störk S, Hoes A, Rutten FH. Chronic obstructive pulmonary disease in heart failure: accurate diagnosis and treatment. Eur J Heart Fail. 2014;16(12):1273–82. CrossRefPubMed
8.
go back to reference Thiadens HA, Bock GH de, Dekker FW, Huysman JA, Houwelingen JC van, Springer MP, et al. Identifying asthma and chronic obstructive pulmonary disease in patients with persistent cough presenting to general practitioners: descriptive study. BMJ. 1998;316:1286–90. CrossRefPubMedPubMedCentral Thiadens HA, Bock GH de, Dekker FW, Huysman JA, Houwelingen JC van, Springer MP, et al. Identifying asthma and chronic obstructive pulmonary disease in patients with persistent cough presenting to general practitioners: descriptive study. BMJ. 1998;316:1286–90. CrossRefPubMedPubMedCentral
9.
go back to reference Kelder JC, Cramer MJ, Wijngaarden J van, Tooren R van, Mosterd A, Moons KG, Lammers JW, Cowie MR, Grobbee DE, Hoes AW. The diagnostic value of physical examination and additional testing in primary care patients with suspected heart failure. Circulation. 2011;124:2865–73. CrossRefPubMed Kelder JC, Cramer MJ, Wijngaarden J van, Tooren R van, Mosterd A, Moons KG, Lammers JW, Cowie MR, Grobbee DE, Hoes AW. The diagnostic value of physical examination and additional testing in primary care patients with suspected heart failure. Circulation. 2011;124:2865–73. CrossRefPubMed
10.
go back to reference Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37:2893–962. CrossRef Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37:2893–962. CrossRef
11.
go back to reference Rutten FH, Cramer M‑JM, Lammers J‑WJ, Grobbee DE, Hoes AW. Heart failure and chronic obstructive pulmonary disease: an ignored combination? Eur J Heart Fail. 2006;8:706–11. CrossRefPubMed Rutten FH, Cramer M‑JM, Lammers J‑WJ, Grobbee DE, Hoes AW. Heart failure and chronic obstructive pulmonary disease: an ignored combination? Eur J Heart Fail. 2006;8:706–11. CrossRefPubMed
12.
go back to reference Rutten FH, Moons KCM, Cramer M‑JM, Grobbee DE, Zuithoff NPA, Lammers J‑WJ, Hoes AW. Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ. 2005;331:1379–85. CrossRefPubMedPubMedCentral Rutten FH, Moons KCM, Cramer M‑JM, Grobbee DE, Zuithoff NPA, Lammers J‑WJ, Hoes AW. Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ. 2005;331:1379–85. CrossRefPubMedPubMedCentral
13.
go back to reference Güder G, Brenner S, Angermann CE, Ertl G, Held M, Sachs APE, et al. GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study. Respir Res. 2012;13:13. CrossRefPubMedPubMedCentral Güder G, Brenner S, Angermann CE, Ertl G, Held M, Sachs APE, et al. GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study. Respir Res. 2012;13:13. CrossRefPubMedPubMedCentral
14.
go back to reference Güder G, Rutten FH, Brenner S, Angermann CE, Berliner D, Ertl G, Jany B, Lammers JWJ, Hoes AW, Störck S. The impact of heart failure on the classification of COPD severity. J Card Fail. 2012;18:637–44. CrossRefPubMed Güder G, Rutten FH, Brenner S, Angermann CE, Berliner D, Ertl G, Jany B, Lammers JWJ, Hoes AW, Störck S. The impact of heart failure on the classification of COPD severity. J Card Fail. 2012;18:637–44. CrossRefPubMed
15.
go back to reference Sin DD, Man SF. Why are patients with COPD at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003;7:1514–9. CrossRef Sin DD, Man SF. Why are patients with COPD at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003;7:1514–9. CrossRef
16.
go back to reference Oudijk EJ, Lammers JW, Koenderman L. Systemic inflammation in chronic obstructive pulmonary disease. Eur Respir J Suppl. 2003;46:5s–13s. CrossRefPubMed Oudijk EJ, Lammers JW, Koenderman L. Systemic inflammation in chronic obstructive pulmonary disease. Eur Respir J Suppl. 2003;46:5s–13s. CrossRefPubMed
17.
go back to reference Hole DJ, Watt GC, Davey S, Hart CL, Gillis CR, Hawthorne VM. Impaired lung function and mortality risk in men and women: findings from the Renfrew and paisley prospective population study. BMJ. 1996;313:711–5. CrossRefPubMedPubMedCentral Hole DJ, Watt GC, Davey S, Hart CL, Gillis CR, Hawthorne VM. Impaired lung function and mortality risk in men and women: findings from the Renfrew and paisley prospective population study. BMJ. 1996;313:711–5. CrossRefPubMedPubMedCentral
18.
go back to reference Zureik M, Kauffmann F, Touboul PJ, Courbon D, Ducimetiere P. Association between peak expiratory flow and the development of carotid atherosclerotic plaques. Arch Intern Med. 2001;161:1669–76. CrossRefPubMed Zureik M, Kauffmann F, Touboul PJ, Courbon D, Ducimetiere P. Association between peak expiratory flow and the development of carotid atherosclerotic plaques. Arch Intern Med. 2001;161:1669–76. CrossRefPubMed
19.
go back to reference Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, et al. Inflammatory markers and risk of heart failure in elderly subjects without prior infarction. Circulation. 2003;107:1486–91. CrossRefPubMed Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, et al. Inflammatory markers and risk of heart failure in elderly subjects without prior infarction. Circulation. 2003;107:1486–91. CrossRefPubMed
20.
go back to reference Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B, et al. TOPCAT Investigators. Spironolactone for heart failure with preserved ejection fraction. N Engl J Med. 2014;370(15):1383–92. CrossRefPubMed Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B, et al. TOPCAT Investigators. Spironolactone for heart failure with preserved ejection fraction. N Engl J Med. 2014;370(15):1383–92. CrossRefPubMed
21.
go back to reference Denus S de, O’Meara E, Desai AS, Claggett B, Lewis EF, Leclair G, et al. Spironolactone metabolites in TOPCAT – new insights into regional variation. N Engl J Med. 2017;376(17):1690–2. CrossRefPubMedPubMedCentral Denus S de, O’Meara E, Desai AS, Claggett B, Lewis EF, Leclair G, et al. Spironolactone metabolites in TOPCAT – new insights into regional variation. N Engl J Med. 2017;376(17):1690–2. CrossRefPubMedPubMedCentral
22.
go back to reference Solomon SD, Claggett B, Lewis EF, Desai A, Anand I, Sweitzer NK, et al. TOPCAT Investigators. Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction. Eur Heart J. 2016;37(5):455–62. CrossRefPubMed Solomon SD, Claggett B, Lewis EF, Desai A, Anand I, Sweitzer NK, et al. TOPCAT Investigators. Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction. Eur Heart J. 2016;37(5):455–62. CrossRefPubMed
23.
go back to reference Boudestein LC, Rutten FH, Cramer MJ, Lammers JW, Hoes AW. The impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease. Eur J Heart Fail. 2009;11:1182–8. CrossRefPubMed Boudestein LC, Rutten FH, Cramer MJ, Lammers JW, Hoes AW. The impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease. Eur J Heart Fail. 2009;11:1182–8. CrossRefPubMed
Metagegevens
Titel
Hartfalen en COPD
Auteur
Prof. dr. Frans H. Rutten
Publicatiedatum
15-06-2018
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Bijblijven / Uitgave 6/2018
Print ISSN: 0168-9428
Elektronisch ISSN: 1876-4916
DOI
https://doi.org/10.1007/s12414-018-0328-0

Andere artikelen Uitgave 6/2018

Bijblijven 6/2018 Naar de uitgave